Radiation 'Primer' tested to boost chemo power against aggressive breast cancer
NCT ID NCT03978663
Summary
This study is testing if giving a short, targeted course of radiation before standard chemotherapy can improve treatment results for people with high-risk breast cancer. The radiation aims to 'prime' the immune system to help the body fight the cancer. Researchers will measure if the combined treatment leads to a complete disappearance of cancer cells at surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
London Regional Cancer Program
London, Ontario, Canada
Conditions
Explore the condition pages connected to this study.